Details

Last Funding Type

Series C

Last Funding Money Raised

$34.80M

Industries

Biotechnology,Health Care,Medical,Therapeutics

Founded date

Apr 1, 2000

Number Of Employee

1 - 10

Operating Status

Active

TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States.


Its product portfolio includes both candidates from its drug targeting platforms and in-licensed and acquired product candidates. As of August 31, 2010, its pipeline includes three clinical development programs. It also has three other clinical-stage product candidates, for which it is seeking business development partners, and it has four preclinical product candidates it is developing, three of which are based upon its drug-targeting platforms.